Profile of Specific Cancer Types in Patients Undergoing Curative Radiotherapy: Findings from a One-Year Descriptive Study

Share:
  • Articles
  • Submited: December 24, 2024
  • Published: November 17, 2025

Abstract

Background: The incidence and mortality rates of cancer have risen rapidly worldwide, driven by an aging population, urbanization, sedentary lifestyles, economic development, and increased tobacco and alcohol consumption.

Objective: This study aimed to evaluate the one-year occurrence of cancer and the sociodemographic and clinical features of patients receiving curative radiotherapy at Tikur Anbessa Specialized Hospital.

Methodology: We conducted a cross-sectional descriptive study on cancer patients receiving curative radiotherapy at Tikur Anbessa Specialized Hospital in Addis Ababa, Ethiopia, from April 2021 to March 2022. A standardized questionnaire was used to collect sociodemographic and clinical data. Descriptive statistics were analyzed using SPSS version 24, with a significance level set at 0.05.

Results: A total of 64 patients (44 females and 20 males) were analyzed. The majority (42.2%) were aged 45 to 64 years, and 70% resided in urban areas, where a higher incidence of gynecologic cancer was noted. Most patients (78%) had locally advanced cancer, and 84.4% (54) were unaware of their cancer diagnosis. Head and neck cancer was the most prevalent, accounting for 31.3% (20 cases), while cervical cancer was the leading type among women, with 17 cases (38.6%), of which 15.9% (7) were HIV positive.

Conclusion: The findings indicate that head and neck cancer is the most prevalent type of cancer, with cervical cancer as the leading cause among women. Most patients presented at a locally advanced stage, and many lacked awareness of cancer. Awareness-raising initiatives are crucial to enhance public knowledge about cancer, facilitating early detection and treatment.

 

Downloads

Download data is not yet available.

References

  1. References
  2. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–63.
  3. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209–49.
  4. Omotoso O, Teibo JO, Atiba FA, Oladimeji T, Paimo OK, Ataya FS, et al. Addressing cancer care inequities in sub-Saharan Africa: current challenges and proposed solutions. Int J Equity Health [Internet]. 2023;22(1):1–14. Available from: https://doi.org/10.1186/s12939-023-01962-y
  5. Yuan H, Kehm RD, Daaboul JM, Lloyd SE, McDonald JA, Mu L, et al. Cancer incidence trends in NeYorkState and associations with common population-level exposures 2010–2018: an ecological
  6. study. Sci Rep [Internet]. 2024;14(1). Available from: https://doi.org/10.1038/s41598-024-56634-w
  7. Rick T, Habtamu B, Tigeneh W, Abreha A, van Norden Y, Grover S, et al. Patterns of Care of Cancers and Radiotherapy in Ethiopia. J Glob Oncol. 2019;5:1–8.
  8. FMoH. National Cancer Control Plan 2016 - 2020 of Ethiopia. Dis Prev Control Dir [Internet]. 2015;(October 2015):83. Available from: http://bmg.bund.de/en.html
  9. WHO. Global Cancer Observatory Ethiopia Fact Sheet. Int agency Res cancer. 2021;133:2020–1.
  10. Zubizarreta ERE. RADIOTHERAPY IN CANCER CARE: FACING THE GLOBAL CHALLENGE. J Hepatol. 2017;21(4):634–40.
  11. UNMC C of M. What is Radiation Therapy? 2025;6. Available from: https://www.unmc.edu/radonc/patient-care/what_is.html
  12. Whitney E. Zahnd, Aimee S. James, Wiley D. Jenkins, Sonya R. Izadi, Amanda J. Fogleman, MEng, David E. Steward, Graham A. Colditz and LB. Rural-Urban Differences in Cancer Incidence and Trends in the United States. PMC. 2019;27(11):1265–74.
  13. Yuan S, Xie SH. Urban–rural disparity in cancer incidence in China, 2008–2012: A cross-sectional analysis of data from 36 cancer registers. BMJ Open. 2021;11(4):2008–12.
  14. Zheng W, Zhang H, Wang D, Wang C, Zhang S, Shen C, et al. Urban-rural disparity in cancer mortality and changing trend in Tianjin, China, during 1999 and 2016. BMC Cancer. 2021;21(1):1–8.
  15. Subedi R, Budukh A, Chapagain S, Gyanwali P, Gyawali B, Khadka K, et al. Differences in cancer incidence and pattern between urban and rural Nepal: One-year experience from two population-based cancer registries. Ecancermedicalscience. 2021;15:1–11.
  16. Iseh KR, Abdullahi M, Aliyu DJ, Amutta S, Yikawe SS, Solomon JH. Clinical and Histological Patterns of Oropharyngeal Tumors in Selected Health Institutions in North Western Nigeria. Int J Otolaryngol Head & Neck Surg. 2015;04(02):55–60.
  17. Saleem A, Bekele A, Fitzpatrick MB, Mahmoud EA, Lin AW, Velasco HE, et al. Knowledge and awareness of cervical cancer in Southwestern Ethiopia is lacking: A descriptive analysis. PLoS One [Internet]. 2019;14(11):1–11. Available from: http://dx.doi.org/10.1371/journal.pone.0215117
  18. Queen AN. Cancer awareness. J Am Dent Assoc. 1999;130(11):1556.
  19. Al Qadire M. Awareness of Cancer Signs and Barriers to Help Seeking: a National Survey. J Cancer Educ. 2018;33(6):1206–12.
  20. Svendsen RP, Paulsen MS, Larsen PV, Hansen BL, Støvring H, Jarbøl DE, et al. Associations between reporting of cancer alarm symptoms and socioeconomic and demographic determinants: a population-based, cross-sectional study. BMC Public Health. 2012;12:686.
  21. Jones SC, Gregory P, Nehill C, Barrie L, Luxford K, Nelson A, et al. Australian women’s awareness of breast cancer symptoms and responses to potential symptoms. Cancer Causes Control. 2010;21(6):945–58.
  22. Su TT, Goh JY, Tan J, Muhaimah AR, Pigeneswaren Y, Khairun NS, et al. Level of colorectal cancer awareness: A cross sectional exploratory study among multi-ethnic rural population in Malaysia. BMC Cancer. 2013;13.
  23. Ravichandran K, Mohamed G, Al-Hamdan NA. Public knowledge on cancer and its determinants among Saudis in the Riyadh region of Saudi Arabia. Asian Pacific J Cancer Prev. 2010;11(5):1175–80.
  24. Feizi A, Kazemnejad A, Hosseini M, Parsa-Yekta Z, Jamali J. Assessing awareness level about warning signs of cancer and its determinants in an Iranian general population. J Heal Popul Nutr. 2011;29(6):656–9.
  25. Waller J, Robb K, Stubbings S, Ramirez A, Macleod U, Austoker J, et al. Awareness of cancer symptoms and anticipated help seeking among ethnic minority groups in England. Br J Cancer [Internet]. 2009;101(S2):S24–30. Available from: http://dx.doi.org/10.1038/sj.bjc.6605387
  26. Mulugeta W, Beletech F, Tseganesh A. Human immune deficiency virus among cervical cancer patients at Tikur Anbessa Specialized Hospital, Ethiopia: a cross sectional study. BMC Womens Health [Internet]. 2021;21(1):1–7. Available from: https://doi.org/10.1186/s12905-021-01438-7
  27. Ketsela L, Shiferaw N, Lukman Y. Sero-prevalence of hiv among patients with cervical cancer managed at the tikur anbassa hospital addis ababa, ethiopia. East Afr Med J. 2018;95(4):1438–51.
  28. Traore B, Bah TS, Traore FA, Sow MS, Diane S, Keita M, et al. The Prevalence of HIV in Cancer Patients at the Surgical Oncology Unit of Donka University Hospital of Conakry (Guinea). J Cancer Epidemiol. 2015;2015.
  29. Gormley M, Creaney G, Schache A, Ingarfield K, Conway DI. Reviewing the epidemiology of head and neck cancer: definitions, trends and risk factors. Br Dent J. 2022;233(9):780–6.
  30. Dhanushkodi M, Sridevi V, Shanta V, Rama R, Swaminathan R, Selvaluxmy G, et al. Locally Advanced Breast Cancer (LABC): Real-World Outcome of Patients From Cancer Institute, Chennai. JCO Glob Oncol. 2021;(7):767–81.
How to Cite
Zebene, E., Medhin, D. H., Woldetsadik, D. E., & Woldemichael, P. G. (2025). Profile of Specific Cancer Types in Patients Undergoing Curative Radiotherapy: Findings from a One-Year Descriptive Study. Ethiopian Medical Journal, 63(2). Retrieved from https://www.emjema.org/index.php/EMJ/article/view/2816

Send mail to Author


Send Cancel